nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—FGFR3—skull—Paget's disease of bone	0.0263	0.386	CbGeAlD
Ponatinib—RET—parathyroid gland—Paget's disease of bone	0.0177	0.26	CbGeAlD
Ponatinib—FGFR2—skull—Paget's disease of bone	0.0172	0.253	CbGeAlD
Ponatinib—FGFR3—NOTCH1 regulation of human endothelial cell calcification—ALPL—Paget's disease of bone	0.0135	0.0453	CbGpPWpGaD
Ponatinib—PDGFRA—Osteoblast Signaling—TNFRSF11B—Paget's disease of bone	0.0104	0.0349	CbGpPWpGaD
Ponatinib—PDGFRA—Osteoblast Signaling—BGLAP—Paget's disease of bone	0.00931	0.0313	CbGpPWpGaD
Ponatinib—LYN—PECAM1 interactions—INPP5D—Paget's disease of bone	0.00891	0.0299	CbGpPWpGaD
Ponatinib—LCK—PECAM1 interactions—INPP5D—Paget's disease of bone	0.0073	0.0245	CbGpPWpGaD
Ponatinib—LYN—RANKL/RANK Signaling Pathway—TNFRSF11A—Paget's disease of bone	0.00704	0.0237	CbGpPWpGaD
Ponatinib—KDR—Signaling events mediated by TCPTP—CSF1—Paget's disease of bone	0.00693	0.0233	CbGpPWpGaD
Ponatinib—FGFR4—FGF signaling pathway—BGLAP—Paget's disease of bone	0.00669	0.0225	CbGpPWpGaD
Ponatinib—SRC—PECAM1 interactions—INPP5D—Paget's disease of bone	0.00647	0.0217	CbGpPWpGaD
Ponatinib—SRC—RANKL/RANK Signaling Pathway—TNFRSF11A—Paget's disease of bone	0.00511	0.0172	CbGpPWpGaD
Ponatinib—FGFR3—FGF signaling pathway—BGLAP—Paget's disease of bone	0.00495	0.0166	CbGpPWpGaD
Ponatinib—KDR—Integrins in angiogenesis—CSF1—Paget's disease of bone	0.00482	0.0162	CbGpPWpGaD
Ponatinib—KDR—Notch-mediated HES/HEY network—BGLAP—Paget's disease of bone	0.00482	0.0162	CbGpPWpGaD
Ponatinib—FGFR3—Endochondral Ossification—ALPL—Paget's disease of bone	0.00466	0.0157	CbGpPWpGaD
Ponatinib—KIT—Differentiation Pathway—CSF1—Paget's disease of bone	0.00465	0.0156	CbGpPWpGaD
Ponatinib—TEK—Cell surface interactions at the vascular wall—INPP5D—Paget's disease of bone	0.00425	0.0143	CbGpPWpGaD
Ponatinib—LYN—EPO signaling pathway—INPP5D—Paget's disease of bone	0.00407	0.0137	CbGpPWpGaD
Ponatinib—LYN—Signaling events mediated by PTP1B—CSF1—Paget's disease of bone	0.00364	0.0122	CbGpPWpGaD
Ponatinib—LYN—GMCSF-mediated signaling events—INPP5D—Paget's disease of bone	0.00362	0.0122	CbGpPWpGaD
Ponatinib—CYP3A4—urine—Paget's disease of bone	0.00349	0.0512	CbGeAlD
Ponatinib—CYP2D6—urine—Paget's disease of bone	0.00343	0.0504	CbGeAlD
Ponatinib—FGFR2—FGF signaling pathway—BGLAP—Paget's disease of bone	0.0034	0.0114	CbGpPWpGaD
Ponatinib—SRC—Signaling events mediated by TCPTP—CSF1—Paget's disease of bone	0.00326	0.0109	CbGpPWpGaD
Ponatinib—Ecchymosis—Risedronate—Paget's disease of bone	0.00324	0.0051	CcSEcCtD
Ponatinib—Gastrointestinal pain—Tiludronate—Paget's disease of bone	0.00319	0.00503	CcSEcCtD
Ponatinib—FGFR1—FGF signaling pathway—BGLAP—Paget's disease of bone	0.00317	0.0107	CbGpPWpGaD
Ponatinib—LYN—Interleukin-3, 5 and GM-CSF signaling—INPP5D—Paget's disease of bone	0.00315	0.0106	CbGpPWpGaD
Ponatinib—Musculoskeletal pain—Zoledronate—Paget's disease of bone	0.00314	0.00496	CcSEcCtD
Ponatinib—Neck pain—Zoledronate—Paget's disease of bone	0.00314	0.00496	CcSEcCtD
Ponatinib—Pancytopenia—Etidronic acid—Paget's disease of bone	0.00312	0.00492	CcSEcCtD
Ponatinib—LYN—Class I PI3K signaling events—INPP5D—Paget's disease of bone	0.00309	0.0104	CbGpPWpGaD
Ponatinib—Abdominal pain—Tiludronate—Paget's disease of bone	0.00308	0.00486	CcSEcCtD
Ponatinib—LYN—RANKL/RANK Signaling Pathway—TNFRSF11B—Paget's disease of bone	0.00307	0.0103	CbGpPWpGaD
Ponatinib—Influenza like illness—Zoledronate—Paget's disease of bone	0.00302	0.00476	CcSEcCtD
Ponatinib—FGFR1—Endochondral Ossification—ALPL—Paget's disease of bone	0.00299	0.01	CbGpPWpGaD
Ponatinib—KIT—Kit receptor signaling pathway—INPP5D—Paget's disease of bone	0.00298	0.01	CbGpPWpGaD
Ponatinib—LCK—Signaling events mediated by PTP1B—CSF1—Paget's disease of bone	0.00298	0.01	CbGpPWpGaD
Ponatinib—Dry skin—Alendronate—Paget's disease of bone	0.00297	0.00468	CcSEcCtD
Ponatinib—LYN—IL-3 Signaling Pathway—INPP5D—Paget's disease of bone	0.00289	0.00972	CbGpPWpGaD
Ponatinib—Neuropathy peripheral—Etidronic acid—Paget's disease of bone	0.00287	0.00452	CcSEcCtD
Ponatinib—Abdominal distension—Alendronate—Paget's disease of bone	0.00282	0.00444	CcSEcCtD
Ponatinib—Asthenia—Tiludronate—Paget's disease of bone	0.0028	0.00441	CcSEcCtD
Ponatinib—ABL1—Validated transcriptional targets of TAp63 isoforms—PML—Paget's disease of bone	0.00276	0.00927	CbGpPWpGaD
Ponatinib—LCK—Downstream TCR signaling—INPP5D—Paget's disease of bone	0.00273	0.00918	CbGpPWpGaD
Ponatinib—Cardiac failure congestive—Pamidronate—Paget's disease of bone	0.00272	0.00429	CcSEcCtD
Ponatinib—Abdominal discomfort—Alendronate—Paget's disease of bone	0.00268	0.00423	CcSEcCtD
Ponatinib—Diarrhoea—Tiludronate—Paget's disease of bone	0.00267	0.00421	CcSEcCtD
Ponatinib—SRC—Signaling events mediated by PTP1B—CSF1—Paget's disease of bone	0.00264	0.00887	CbGpPWpGaD
Ponatinib—Atrial fibrillation—Pamidronate—Paget's disease of bone	0.00261	0.00411	CcSEcCtD
Ponatinib—Pain in extremity—Risedronate—Paget's disease of bone	0.0026	0.00409	CcSEcCtD
Ponatinib—Dizziness—Tiludronate—Paget's disease of bone	0.00258	0.00406	CcSEcCtD
Ponatinib—LCK—Class I PI3K signaling events—INPP5D—Paget's disease of bone	0.00254	0.00853	CbGpPWpGaD
Ponatinib—Cardiac failure—Pamidronate—Paget's disease of bone	0.00253	0.00399	CcSEcCtD
Ponatinib—Lethargy—Pamidronate—Paget's disease of bone	0.00252	0.00397	CcSEcCtD
Ponatinib—LYN—Kit receptor signaling pathway—INPP5D—Paget's disease of bone	0.00249	0.00838	CbGpPWpGaD
Ponatinib—Gastrointestinal haemorrhage—Pamidronate—Paget's disease of bone	0.00247	0.00389	CcSEcCtD
Ponatinib—LCK—Interleukin-2 signaling—INPP5D—Paget's disease of bone	0.00245	0.00823	CbGpPWpGaD
Ponatinib—Headache—Tiludronate—Paget's disease of bone	0.00244	0.00385	CcSEcCtD
Ponatinib—Stomatitis—Alendronate—Paget's disease of bone	0.00243	0.00383	CcSEcCtD
Ponatinib—LYN—Fc-epsilon receptor I signaling in mast cells—INPP5D—Paget's disease of bone	0.00243	0.00815	CbGpPWpGaD
Ponatinib—ABL1—Apoptosis-related network due to altered Notch3 in ovarian cancer—SQSTM1—Paget's disease of bone	0.00242	0.00814	CbGpPWpGaD
Ponatinib—SRC—Interleukin-11 Signaling Pathway—BGLAP—Paget's disease of bone	0.00238	0.00802	CbGpPWpGaD
Ponatinib—Atrial fibrillation—Zoledronate—Paget's disease of bone	0.00238	0.00375	CcSEcCtD
Ponatinib—ABL1—Regulation of retinoblastoma protein—BGLAP—Paget's disease of bone	0.00237	0.00795	CbGpPWpGaD
Ponatinib—LYN—RANKL/RANK Signaling Pathway—SQSTM1—Paget's disease of bone	0.00236	0.00794	CbGpPWpGaD
Ponatinib—Breast disorder—Risedronate—Paget's disease of bone	0.00235	0.0037	CcSEcCtD
Ponatinib—Nasopharyngitis—Risedronate—Paget's disease of bone	0.00232	0.00366	CcSEcCtD
Ponatinib—Alopecia—Etidronic acid—Paget's disease of bone	0.00232	0.00366	CcSEcCtD
Ponatinib—Nausea—Tiludronate—Paget's disease of bone	0.00232	0.00365	CcSEcCtD
Ponatinib—Blood creatinine increased—Pamidronate—Paget's disease of bone	0.00231	0.00365	CcSEcCtD
Ponatinib—Lethargy—Zoledronate—Paget's disease of bone	0.0023	0.00363	CcSEcCtD
Ponatinib—ABL1—DNA Damage Response—PML—Paget's disease of bone	0.00229	0.00771	CbGpPWpGaD
Ponatinib—Erythema—Etidronic acid—Paget's disease of bone	0.00229	0.00361	CcSEcCtD
Ponatinib—SRC—Integrins in angiogenesis—CSF1—Paget's disease of bone	0.00226	0.00761	CbGpPWpGaD
Ponatinib—Abdominal distension—Risedronate—Paget's disease of bone	0.00226	0.00356	CcSEcCtD
Ponatinib—Pain in extremity—Zoledronate—Paget's disease of bone	0.00226	0.00356	CcSEcCtD
Ponatinib—LYN—BCR signaling pathway—INPP5D—Paget's disease of bone	0.00225	0.00757	CbGpPWpGaD
Ponatinib—Haemoglobin—Alendronate—Paget's disease of bone	0.00225	0.00355	CcSEcCtD
Ponatinib—Hypokalaemia—Pamidronate—Paget's disease of bone	0.00225	0.00354	CcSEcCtD
Ponatinib—SRC—Class I PI3K signaling events—INPP5D—Paget's disease of bone	0.00225	0.00755	CbGpPWpGaD
Ponatinib—Haemorrhage—Alendronate—Paget's disease of bone	0.00224	0.00353	CcSEcCtD
Ponatinib—SRC—RANKL/RANK Signaling Pathway—TNFRSF11B—Paget's disease of bone	0.00222	0.00748	CbGpPWpGaD
Ponatinib—ABL1—miRNA Regulation of DNA Damage Response—PML—Paget's disease of bone	0.00222	0.00745	CbGpPWpGaD
Ponatinib—Nasopharyngitis—Pamidronate—Paget's disease of bone	0.00221	0.00348	CcSEcCtD
Ponatinib—Oedema peripheral—Alendronate—Paget's disease of bone	0.00221	0.00348	CcSEcCtD
Ponatinib—Muscle spasms—Etidronic acid—Paget's disease of bone	0.0022	0.00347	CcSEcCtD
Ponatinib—Angina pectoris—Risedronate—Paget's disease of bone	0.00219	0.00345	CcSEcCtD
Ponatinib—ABL1—Neurotrophic factor-mediated Trk receptor signaling—SQSTM1—Paget's disease of bone	0.00217	0.00728	CbGpPWpGaD
Ponatinib—Abdominal discomfort—Risedronate—Paget's disease of bone	0.00215	0.00339	CcSEcCtD
Ponatinib—Anaemia—Etidronic acid—Paget's disease of bone	0.00211	0.00333	CcSEcCtD
Ponatinib—Blood creatinine increased—Zoledronate—Paget's disease of bone	0.00211	0.00333	CcSEcCtD
Ponatinib—SRC—IL-3 Signaling Pathway—INPP5D—Paget's disease of bone	0.0021	0.00705	CbGpPWpGaD
Ponatinib—Dehydration—Zoledronate—Paget's disease of bone	0.0021	0.00331	CcSEcCtD
Ponatinib—Upper respiratory tract infection—Risedronate—Paget's disease of bone	0.00209	0.00329	CcSEcCtD
Ponatinib—Hypokalaemia—Zoledronate—Paget's disease of bone	0.00205	0.00324	CcSEcCtD
Ponatinib—Leukopenia—Etidronic acid—Paget's disease of bone	0.00205	0.00323	CcSEcCtD
Ponatinib—LCK—TCR signaling—INPP5D—Paget's disease of bone	0.00204	0.00686	CbGpPWpGaD
Ponatinib—ABL1—p73 transcription factor network—PML—Paget's disease of bone	0.00204	0.00684	CbGpPWpGaD
Ponatinib—SRC—FGF signaling pathway—BGLAP—Paget's disease of bone	0.00202	0.0068	CbGpPWpGaD
Ponatinib—Nasopharyngitis—Zoledronate—Paget's disease of bone	0.00202	0.00318	CcSEcCtD
Ponatinib—Pneumonia—Risedronate—Paget's disease of bone	0.00201	0.00317	CcSEcCtD
Ponatinib—Infestation NOS—Risedronate—Paget's disease of bone	0.002	0.00316	CcSEcCtD
Ponatinib—Infestation—Risedronate—Paget's disease of bone	0.002	0.00316	CcSEcCtD
Ponatinib—Neutropenia—Pamidronate—Paget's disease of bone	0.002	0.00315	CcSEcCtD
Ponatinib—Upper respiratory tract infection—Pamidronate—Paget's disease of bone	0.00198	0.00313	CcSEcCtD
Ponatinib—Alopecia—Alendronate—Paget's disease of bone	0.00198	0.00312	CcSEcCtD
Ponatinib—Abdominal distension—Zoledronate—Paget's disease of bone	0.00196	0.00309	CcSEcCtD
Ponatinib—Erythema—Alendronate—Paget's disease of bone	0.00195	0.00307	CcSEcCtD
Ponatinib—Arthralgia—Etidronic acid—Paget's disease of bone	0.00195	0.00307	CcSEcCtD
Ponatinib—Urinary tract infection—Risedronate—Paget's disease of bone	0.00195	0.00307	CcSEcCtD
Ponatinib—Pneumonia—Pamidronate—Paget's disease of bone	0.00191	0.00302	CcSEcCtD
Ponatinib—Infestation—Pamidronate—Paget's disease of bone	0.0019	0.003	CcSEcCtD
Ponatinib—Infestation NOS—Pamidronate—Paget's disease of bone	0.0019	0.003	CcSEcCtD
Ponatinib—Hepatobiliary disease—Risedronate—Paget's disease of bone	0.00189	0.00298	CcSEcCtD
Ponatinib—LYN—CXCR4-mediated signaling events—INPP5D—Paget's disease of bone	0.00188	0.00631	CbGpPWpGaD
Ponatinib—Muscle spasms—Alendronate—Paget's disease of bone	0.00187	0.00295	CcSEcCtD
Ponatinib—Abdominal discomfort—Zoledronate—Paget's disease of bone	0.00187	0.00295	CcSEcCtD
Ponatinib—LCK—TCR signaling in naïve CD4+ T cells—INPP5D—Paget's disease of bone	0.00187	0.00628	CbGpPWpGaD
Ponatinib—SRC—AGE/RAGE pathway—ALPL—Paget's disease of bone	0.00186	0.00626	CbGpPWpGaD
Ponatinib—Infection—Etidronic acid—Paget's disease of bone	0.00186	0.00292	CcSEcCtD
Ponatinib—Stomatitis—Pamidronate—Paget's disease of bone	0.00185	0.00292	CcSEcCtD
Ponatinib—Pancytopenia—Zoledronate—Paget's disease of bone	0.00185	0.00292	CcSEcCtD
Ponatinib—Urinary tract infection—Pamidronate—Paget's disease of bone	0.00185	0.00292	CcSEcCtD
Ponatinib—Neutropenia—Zoledronate—Paget's disease of bone	0.00182	0.00287	CcSEcCtD
Ponatinib—Upper respiratory tract infection—Zoledronate—Paget's disease of bone	0.00181	0.00286	CcSEcCtD
Ponatinib—SRC—Kit receptor signaling pathway—INPP5D—Paget's disease of bone	0.00181	0.00608	CbGpPWpGaD
Ponatinib—Haemoglobin—Risedronate—Paget's disease of bone	0.00181	0.00285	CcSEcCtD
Ponatinib—Anaemia—Alendronate—Paget's disease of bone	0.0018	0.00284	CcSEcCtD
Ponatinib—Haemorrhage—Risedronate—Paget's disease of bone	0.0018	0.00283	CcSEcCtD
Ponatinib—FGFR2—Ectoderm Differentiation—TNFRSF11B—Paget's disease of bone	0.00179	0.00602	CbGpPWpGaD
Ponatinib—Oedema peripheral—Risedronate—Paget's disease of bone	0.00177	0.00279	CcSEcCtD
Ponatinib—Connective tissue disorder—Risedronate—Paget's disease of bone	0.00177	0.00278	CcSEcCtD
Ponatinib—Weight decreased—Zoledronate—Paget's disease of bone	0.00176	0.00278	CcSEcCtD
Ponatinib—Infestation—Zoledronate—Paget's disease of bone	0.00174	0.00274	CcSEcCtD
Ponatinib—Infestation NOS—Zoledronate—Paget's disease of bone	0.00174	0.00274	CcSEcCtD
Ponatinib—Haemoglobin—Pamidronate—Paget's disease of bone	0.00172	0.00271	CcSEcCtD
Ponatinib—SRC—RANKL/RANK Signaling Pathway—SQSTM1—Paget's disease of bone	0.00171	0.00576	CbGpPWpGaD
Ponatinib—Haemorrhage—Pamidronate—Paget's disease of bone	0.00171	0.00269	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Etidronic acid—Paget's disease of bone	0.0017	0.00268	CcSEcCtD
Ponatinib—Stomatitis—Zoledronate—Paget's disease of bone	0.00169	0.00267	CcSEcCtD
Ponatinib—Urinary tract infection—Zoledronate—Paget's disease of bone	0.00169	0.00266	CcSEcCtD
Ponatinib—Eye disorder—Risedronate—Paget's disease of bone	0.00168	0.00265	CcSEcCtD
Ponatinib—Connective tissue disorder—Pamidronate—Paget's disease of bone	0.00168	0.00265	CcSEcCtD
Ponatinib—Paraesthesia—Etidronic acid—Paget's disease of bone	0.00168	0.00264	CcSEcCtD
Ponatinib—LYN—B Cell Receptor Signaling Pathway—INPP5D—Paget's disease of bone	0.00167	0.00563	CbGpPWpGaD
Ponatinib—Cardiac disorder—Risedronate—Paget's disease of bone	0.00167	0.00263	CcSEcCtD
Ponatinib—Myalgia—Alendronate—Paget's disease of bone	0.00166	0.00262	CcSEcCtD
Ponatinib—LYN—Cell surface interactions at the vascular wall—INPP5D—Paget's disease of bone	0.00165	0.00554	CbGpPWpGaD
Ponatinib—Dyspepsia—Etidronic acid—Paget's disease of bone	0.00164	0.00259	CcSEcCtD
Ponatinib—Angiopathy—Risedronate—Paget's disease of bone	0.00163	0.00257	CcSEcCtD
Ponatinib—Mediastinal disorder—Risedronate—Paget's disease of bone	0.00162	0.00255	CcSEcCtD
Ponatinib—Arrhythmia—Risedronate—Paget's disease of bone	0.00161	0.00253	CcSEcCtD
Ponatinib—Constipation—Etidronic acid—Paget's disease of bone	0.0016	0.00252	CcSEcCtD
Ponatinib—Eye disorder—Pamidronate—Paget's disease of bone	0.0016	0.00252	CcSEcCtD
Ponatinib—Cardiac disorder—Pamidronate—Paget's disease of bone	0.00159	0.0025	CcSEcCtD
Ponatinib—Flushing—Pamidronate—Paget's disease of bone	0.00159	0.0025	CcSEcCtD
Ponatinib—Infection—Alendronate—Paget's disease of bone	0.00158	0.00249	CcSEcCtD
Ponatinib—Mental disorder—Risedronate—Paget's disease of bone	0.00157	0.00248	CcSEcCtD
Ponatinib—Malnutrition—Risedronate—Paget's disease of bone	0.00156	0.00247	CcSEcCtD
Ponatinib—Hypoaesthesia—Zoledronate—Paget's disease of bone	0.00155	0.00245	CcSEcCtD
Ponatinib—Angiopathy—Pamidronate—Paget's disease of bone	0.00155	0.00244	CcSEcCtD
Ponatinib—LCK—CXCR4-mediated signaling events—INPP5D—Paget's disease of bone	0.00154	0.00517	CbGpPWpGaD
Ponatinib—Mediastinal disorder—Pamidronate—Paget's disease of bone	0.00154	0.00243	CcSEcCtD
Ponatinib—Oedema peripheral—Zoledronate—Paget's disease of bone	0.00154	0.00242	CcSEcCtD
Ponatinib—LYN—Signaling by Interleukins—INPP5D—Paget's disease of bone	0.00154	0.00516	CbGpPWpGaD
Ponatinib—Connective tissue disorder—Zoledronate—Paget's disease of bone	0.00153	0.00242	CcSEcCtD
Ponatinib—Chills—Pamidronate—Paget's disease of bone	0.00153	0.00242	CcSEcCtD
Ponatinib—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.00153	0.00241	CcSEcCtD
Ponatinib—FGFR4—Signaling by NGF—SQSTM1—Paget's disease of bone	0.00151	0.00509	CbGpPWpGaD
Ponatinib—Back pain—Risedronate—Paget's disease of bone	0.00151	0.00239	CcSEcCtD
Ponatinib—Alopecia—Pamidronate—Paget's disease of bone	0.00151	0.00238	CcSEcCtD
Ponatinib—Muscle spasms—Risedronate—Paget's disease of bone	0.0015	0.00237	CcSEcCtD
Ponatinib—Malnutrition—Pamidronate—Paget's disease of bone	0.00149	0.00234	CcSEcCtD
Ponatinib—Erythema—Pamidronate—Paget's disease of bone	0.00149	0.00234	CcSEcCtD
Ponatinib—Abdominal pain—Etidronic acid—Paget's disease of bone	0.00148	0.00233	CcSEcCtD
Ponatinib—Eye disorder—Zoledronate—Paget's disease of bone	0.00146	0.0023	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Alendronate—Paget's disease of bone	0.00145	0.00229	CcSEcCtD
Ponatinib—Flushing—Zoledronate—Paget's disease of bone	0.00145	0.00228	CcSEcCtD
Ponatinib—Cardiac disorder—Zoledronate—Paget's disease of bone	0.00145	0.00228	CcSEcCtD
Ponatinib—Anaemia—Risedronate—Paget's disease of bone	0.00145	0.00228	CcSEcCtD
Ponatinib—Back pain—Pamidronate—Paget's disease of bone	0.00144	0.00227	CcSEcCtD
Ponatinib—Muscle spasms—Pamidronate—Paget's disease of bone	0.00143	0.00225	CcSEcCtD
Ponatinib—SRC—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—INPP5D—Paget's disease of bone	0.00142	0.00476	CbGpPWpGaD
Ponatinib—Angiopathy—Zoledronate—Paget's disease of bone	0.00142	0.00223	CcSEcCtD
Ponatinib—Mediastinal disorder—Zoledronate—Paget's disease of bone	0.00141	0.00222	CcSEcCtD
Ponatinib—Dyspepsia—Alendronate—Paget's disease of bone	0.0014	0.00221	CcSEcCtD
Ponatinib—Chills—Zoledronate—Paget's disease of bone	0.0014	0.00221	CcSEcCtD
Ponatinib—Arrhythmia—Zoledronate—Paget's disease of bone	0.00139	0.0022	CcSEcCtD
Ponatinib—Alopecia—Zoledronate—Paget's disease of bone	0.00138	0.00217	CcSEcCtD
Ponatinib—LYN—Signaling by Interleukins—SQSTM1—Paget's disease of bone	0.00138	0.00463	CbGpPWpGaD
Ponatinib—Anaemia—Pamidronate—Paget's disease of bone	0.00137	0.00217	CcSEcCtD
Ponatinib—LCK—B Cell Receptor Signaling Pathway—INPP5D—Paget's disease of bone	0.00137	0.00461	CbGpPWpGaD
Ponatinib—Mental disorder—Zoledronate—Paget's disease of bone	0.00137	0.00216	CcSEcCtD
Ponatinib—Cough—Risedronate—Paget's disease of bone	0.00136	0.00215	CcSEcCtD
Ponatinib—SRC—CXCR4-mediated signaling events—INPP5D—Paget's disease of bone	0.00136	0.00458	CbGpPWpGaD
Ponatinib—Constipation—Alendronate—Paget's disease of bone	0.00136	0.00214	CcSEcCtD
Ponatinib—Pain—Alendronate—Paget's disease of bone	0.00136	0.00214	CcSEcCtD
Ponatinib—Malnutrition—Zoledronate—Paget's disease of bone	0.00136	0.00214	CcSEcCtD
Ponatinib—Erythema—Zoledronate—Paget's disease of bone	0.00136	0.00214	CcSEcCtD
Ponatinib—Hypertension—Risedronate—Paget's disease of bone	0.00135	0.00213	CcSEcCtD
Ponatinib—LCK—Cell surface interactions at the vascular wall—INPP5D—Paget's disease of bone	0.00135	0.00454	CbGpPWpGaD
Ponatinib—Arthralgia—Risedronate—Paget's disease of bone	0.00133	0.0021	CcSEcCtD
Ponatinib—Myalgia—Risedronate—Paget's disease of bone	0.00133	0.0021	CcSEcCtD
Ponatinib—Leukopenia—Pamidronate—Paget's disease of bone	0.00133	0.0021	CcSEcCtD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.00132	0.00208	CcSEcCtD
Ponatinib—Pruritus—Etidronic acid—Paget's disease of bone	0.00132	0.00208	CcSEcCtD
Ponatinib—Back pain—Zoledronate—Paget's disease of bone	0.00131	0.00207	CcSEcCtD
Ponatinib—Muscle spasms—Zoledronate—Paget's disease of bone	0.00131	0.00206	CcSEcCtD
Ponatinib—LCK—Host Interactions of HIV factors—NUP205—Paget's disease of bone	0.00131	0.00439	CbGpPWpGaD
Ponatinib—Dry mouth—Risedronate—Paget's disease of bone	0.0013	0.00205	CcSEcCtD
Ponatinib—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.0013	0.00205	CcSEcCtD
Ponatinib—Cough—Pamidronate—Paget's disease of bone	0.0013	0.00205	CcSEcCtD
Ponatinib—Hypertension—Pamidronate—Paget's disease of bone	0.00128	0.00202	CcSEcCtD
Ponatinib—Vision blurred—Zoledronate—Paget's disease of bone	0.00128	0.00202	CcSEcCtD
Ponatinib—Diarrhoea—Etidronic acid—Paget's disease of bone	0.00128	0.00201	CcSEcCtD
Ponatinib—Infection—Risedronate—Paget's disease of bone	0.00127	0.002	CcSEcCtD
Ponatinib—Arthralgia—Pamidronate—Paget's disease of bone	0.00127	0.002	CcSEcCtD
Ponatinib—Myalgia—Pamidronate—Paget's disease of bone	0.00127	0.002	CcSEcCtD
Ponatinib—LCK—Signaling by Interleukins—INPP5D—Paget's disease of bone	0.00126	0.00423	CbGpPWpGaD
Ponatinib—Body temperature increased—Alendronate—Paget's disease of bone	0.00126	0.00198	CcSEcCtD
Ponatinib—Abdominal pain—Alendronate—Paget's disease of bone	0.00126	0.00198	CcSEcCtD
Ponatinib—Anaemia—Zoledronate—Paget's disease of bone	0.00126	0.00198	CcSEcCtD
Ponatinib—Nervous system disorder—Risedronate—Paget's disease of bone	0.00125	0.00197	CcSEcCtD
Ponatinib—Skin disorder—Risedronate—Paget's disease of bone	0.00124	0.00195	CcSEcCtD
Ponatinib—Leukopenia—Zoledronate—Paget's disease of bone	0.00122	0.00192	CcSEcCtD
Ponatinib—Oedema—Pamidronate—Paget's disease of bone	0.00121	0.00191	CcSEcCtD
Ponatinib—ABL1—Integrated Breast Cancer Pathway—PML—Paget's disease of bone	0.00121	0.00407	CbGpPWpGaD
Ponatinib—Infection—Pamidronate—Paget's disease of bone	0.00121	0.0019	CcSEcCtD
Ponatinib—SRC—Cell surface interactions at the vascular wall—INPP5D—Paget's disease of bone	0.0012	0.00402	CbGpPWpGaD
Ponatinib—Nervous system disorder—Pamidronate—Paget's disease of bone	0.00119	0.00188	CcSEcCtD
Ponatinib—Thrombocytopenia—Pamidronate—Paget's disease of bone	0.00119	0.00187	CcSEcCtD
Ponatinib—Vomiting—Etidronic acid—Paget's disease of bone	0.00119	0.00187	CcSEcCtD
Ponatinib—Cough—Zoledronate—Paget's disease of bone	0.00119	0.00187	CcSEcCtD
Ponatinib—Rash—Etidronic acid—Paget's disease of bone	0.00118	0.00186	CcSEcCtD
Ponatinib—Dermatitis—Etidronic acid—Paget's disease of bone	0.00118	0.00185	CcSEcCtD
Ponatinib—Hyperhidrosis—Pamidronate—Paget's disease of bone	0.00117	0.00185	CcSEcCtD
Ponatinib—Hypertension—Zoledronate—Paget's disease of bone	0.00117	0.00185	CcSEcCtD
Ponatinib—Headache—Etidronic acid—Paget's disease of bone	0.00117	0.00184	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Risedronate—Paget's disease of bone	0.00116	0.00183	CcSEcCtD
Ponatinib—Arthralgia—Zoledronate—Paget's disease of bone	0.00116	0.00182	CcSEcCtD
Ponatinib—Myalgia—Zoledronate—Paget's disease of bone	0.00116	0.00182	CcSEcCtD
Ponatinib—Insomnia—Risedronate—Paget's disease of bone	0.00115	0.00182	CcSEcCtD
Ponatinib—TEK—Hemostasis—INPP5D—Paget's disease of bone	0.00115	0.00387	CbGpPWpGaD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.00115	0.00181	CcSEcCtD
Ponatinib—FGFR1—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.00115	0.00386	CbGpPWpGaD
Ponatinib—Paraesthesia—Risedronate—Paget's disease of bone	0.00115	0.00181	CcSEcCtD
Ponatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.00114	0.00385	CbGpPWpGaD
Ponatinib—Asthenia—Alendronate—Paget's disease of bone	0.00114	0.0018	CcSEcCtD
Ponatinib—Dyspnoea—Risedronate—Paget's disease of bone	0.00114	0.00179	CcSEcCtD
Ponatinib—Dry mouth—Zoledronate—Paget's disease of bone	0.00113	0.00178	CcSEcCtD
Ponatinib—LCK—Signaling by Interleukins—SQSTM1—Paget's disease of bone	0.00113	0.00379	CbGpPWpGaD
Ponatinib—BCR—Disease—VCP—Paget's disease of bone	0.00113	0.00379	CbGpPWpGaD
Ponatinib—Pruritus—Alendronate—Paget's disease of bone	0.00113	0.00177	CcSEcCtD
Ponatinib—Dyspepsia—Risedronate—Paget's disease of bone	0.00112	0.00177	CcSEcCtD
Ponatinib—FGFR3—Signaling by NGF—SQSTM1—Paget's disease of bone	0.00112	0.00377	CbGpPWpGaD
Ponatinib—Nausea—Etidronic acid—Paget's disease of bone	0.00111	0.00175	CcSEcCtD
Ponatinib—Oedema—Zoledronate—Paget's disease of bone	0.00111	0.00175	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Pamidronate—Paget's disease of bone	0.00111	0.00174	CcSEcCtD
Ponatinib—ABL1—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.00111	0.00372	CbGpPWpGaD
Ponatinib—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.0011	0.00174	CcSEcCtD
Ponatinib—Infection—Zoledronate—Paget's disease of bone	0.0011	0.00174	CcSEcCtD
Ponatinib—Fatigue—Risedronate—Paget's disease of bone	0.0011	0.00174	CcSEcCtD
Ponatinib—Insomnia—Pamidronate—Paget's disease of bone	0.0011	0.00173	CcSEcCtD
Ponatinib—Pain—Risedronate—Paget's disease of bone	0.00109	0.00172	CcSEcCtD
Ponatinib—Constipation—Risedronate—Paget's disease of bone	0.00109	0.00172	CcSEcCtD
Ponatinib—Paraesthesia—Pamidronate—Paget's disease of bone	0.00109	0.00172	CcSEcCtD
Ponatinib—Diarrhoea—Alendronate—Paget's disease of bone	0.00109	0.00172	CcSEcCtD
Ponatinib—Nervous system disorder—Zoledronate—Paget's disease of bone	0.00109	0.00171	CcSEcCtD
Ponatinib—Thrombocytopenia—Zoledronate—Paget's disease of bone	0.00109	0.00171	CcSEcCtD
Ponatinib—Dyspnoea—Pamidronate—Paget's disease of bone	0.00108	0.00171	CcSEcCtD
Ponatinib—Skin disorder—Zoledronate—Paget's disease of bone	0.00108	0.0017	CcSEcCtD
Ponatinib—Hyperhidrosis—Zoledronate—Paget's disease of bone	0.00107	0.00169	CcSEcCtD
Ponatinib—Dyspepsia—Pamidronate—Paget's disease of bone	0.00107	0.00168	CcSEcCtD
Ponatinib—Decreased appetite—Pamidronate—Paget's disease of bone	0.00105	0.00166	CcSEcCtD
Ponatinib—Dizziness—Alendronate—Paget's disease of bone	0.00105	0.00166	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.00105	0.00165	CcSEcCtD
Ponatinib—Fatigue—Pamidronate—Paget's disease of bone	0.00105	0.00165	CcSEcCtD
Ponatinib—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.00104	0.00165	CcSEcCtD
Ponatinib—Constipation—Pamidronate—Paget's disease of bone	0.00104	0.00164	CcSEcCtD
Ponatinib—Pain—Pamidronate—Paget's disease of bone	0.00104	0.00164	CcSEcCtD
Ponatinib—SRC—Senescence and Autophagy in Cancer—SQSTM1—Paget's disease of bone	0.00102	0.00344	CbGpPWpGaD
Ponatinib—Vomiting—Alendronate—Paget's disease of bone	0.00101	0.00159	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Zoledronate—Paget's disease of bone	0.00101	0.00159	CcSEcCtD
Ponatinib—Body temperature increased—Risedronate—Paget's disease of bone	0.00101	0.00159	CcSEcCtD
Ponatinib—Abdominal pain—Risedronate—Paget's disease of bone	0.00101	0.00159	CcSEcCtD
Ponatinib—ABL1—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.001	0.00338	CbGpPWpGaD
Ponatinib—Rash—Alendronate—Paget's disease of bone	0.001	0.00158	CcSEcCtD
Ponatinib—Insomnia—Zoledronate—Paget's disease of bone	0.001	0.00158	CcSEcCtD
Ponatinib—Dermatitis—Alendronate—Paget's disease of bone	0.001	0.00158	CcSEcCtD
Ponatinib—SRC—BDNF signaling pathway—ALPL—Paget's disease of bone	0.000997	0.00335	CbGpPWpGaD
Ponatinib—Headache—Alendronate—Paget's disease of bone	0.000997	0.00157	CcSEcCtD
Ponatinib—Paraesthesia—Zoledronate—Paget's disease of bone	0.000995	0.00157	CcSEcCtD
Ponatinib—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.000992	0.00156	CcSEcCtD
Ponatinib—Dyspnoea—Zoledronate—Paget's disease of bone	0.000988	0.00156	CcSEcCtD
Ponatinib—SRC—TGF-beta Signaling Pathway—PML—Paget's disease of bone	0.000984	0.00331	CbGpPWpGaD
Ponatinib—Dyspepsia—Zoledronate—Paget's disease of bone	0.000976	0.00154	CcSEcCtD
Ponatinib—Decreased appetite—Zoledronate—Paget's disease of bone	0.000964	0.00152	CcSEcCtD
Ponatinib—Abdominal pain—Pamidronate—Paget's disease of bone	0.000959	0.00151	CcSEcCtD
Ponatinib—Body temperature increased—Pamidronate—Paget's disease of bone	0.000959	0.00151	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.000957	0.00151	CcSEcCtD
Ponatinib—Fatigue—Zoledronate—Paget's disease of bone	0.000956	0.00151	CcSEcCtD
Ponatinib—Pain—Zoledronate—Paget's disease of bone	0.000948	0.00149	CcSEcCtD
Ponatinib—Constipation—Zoledronate—Paget's disease of bone	0.000948	0.00149	CcSEcCtD
Ponatinib—Nausea—Alendronate—Paget's disease of bone	0.000945	0.00149	CcSEcCtD
Ponatinib—FGFR4—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000925	0.00311	CbGpPWpGaD
Ponatinib—Asthenia—Risedronate—Paget's disease of bone	0.000916	0.00144	CcSEcCtD
Ponatinib—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.000906	0.00143	CcSEcCtD
Ponatinib—Pruritus—Risedronate—Paget's disease of bone	0.000903	0.00142	CcSEcCtD
Ponatinib—Body temperature increased—Zoledronate—Paget's disease of bone	0.000876	0.00138	CcSEcCtD
Ponatinib—Abdominal pain—Zoledronate—Paget's disease of bone	0.000876	0.00138	CcSEcCtD
Ponatinib—Diarrhoea—Risedronate—Paget's disease of bone	0.000873	0.00138	CcSEcCtD
Ponatinib—Asthenia—Pamidronate—Paget's disease of bone	0.000871	0.00137	CcSEcCtD
Ponatinib—BCR—Disease—NUP205—Paget's disease of bone	0.000863	0.0029	CbGpPWpGaD
Ponatinib—Pruritus—Pamidronate—Paget's disease of bone	0.000859	0.00135	CcSEcCtD
Ponatinib—LCK—HIV Infection—NUP205—Paget's disease of bone	0.000848	0.00285	CbGpPWpGaD
Ponatinib—Dizziness—Risedronate—Paget's disease of bone	0.000844	0.00133	CcSEcCtD
Ponatinib—LYN—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.000841	0.00283	CbGpPWpGaD
Ponatinib—Diarrhoea—Pamidronate—Paget's disease of bone	0.00083	0.00131	CcSEcCtD
Ponatinib—Vomiting—Risedronate—Paget's disease of bone	0.000812	0.00128	CcSEcCtD
Ponatinib—SRC—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.000806	0.00271	CbGpPWpGaD
Ponatinib—Rash—Risedronate—Paget's disease of bone	0.000805	0.00127	CcSEcCtD
Ponatinib—Dermatitis—Risedronate—Paget's disease of bone	0.000804	0.00127	CcSEcCtD
Ponatinib—Dizziness—Pamidronate—Paget's disease of bone	0.000802	0.00127	CcSEcCtD
Ponatinib—Headache—Risedronate—Paget's disease of bone	0.0008	0.00126	CcSEcCtD
Ponatinib—Asthenia—Zoledronate—Paget's disease of bone	0.000795	0.00125	CcSEcCtD
Ponatinib—FGFR4—Disease—VCP—Paget's disease of bone	0.000795	0.00267	CbGpPWpGaD
Ponatinib—SRC—BDNF signaling pathway—SQSTM1—Paget's disease of bone	0.000794	0.00267	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—VCP—Paget's disease of bone	0.00079	0.00266	CbGpPWpGaD
Ponatinib—Pruritus—Zoledronate—Paget's disease of bone	0.000784	0.00124	CcSEcCtD
Ponatinib—Vomiting—Pamidronate—Paget's disease of bone	0.000772	0.00122	CcSEcCtD
Ponatinib—FGFR2—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000771	0.00259	CbGpPWpGaD
Ponatinib—Rash—Pamidronate—Paget's disease of bone	0.000765	0.00121	CcSEcCtD
Ponatinib—Dermatitis—Pamidronate—Paget's disease of bone	0.000764	0.00121	CcSEcCtD
Ponatinib—Headache—Pamidronate—Paget's disease of bone	0.00076	0.0012	CcSEcCtD
Ponatinib—Diarrhoea—Zoledronate—Paget's disease of bone	0.000758	0.0012	CcSEcCtD
Ponatinib—Nausea—Risedronate—Paget's disease of bone	0.000758	0.0012	CcSEcCtD
Ponatinib—KIT—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000757	0.00254	CbGpPWpGaD
Ponatinib—LYN—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.000743	0.0025	CbGpPWpGaD
Ponatinib—Dizziness—Zoledronate—Paget's disease of bone	0.000733	0.00116	CcSEcCtD
Ponatinib—SRC—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000732	0.00246	CbGpPWpGaD
Ponatinib—Nausea—Pamidronate—Paget's disease of bone	0.000721	0.00114	CcSEcCtD
Ponatinib—FGFR1—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000718	0.00241	CbGpPWpGaD
Ponatinib—LYN—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000717	0.00241	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000716	0.00241	CbGpPWpGaD
Ponatinib—Vomiting—Zoledronate—Paget's disease of bone	0.000705	0.00111	CcSEcCtD
Ponatinib—Rash—Zoledronate—Paget's disease of bone	0.000699	0.0011	CcSEcCtD
Ponatinib—Dermatitis—Zoledronate—Paget's disease of bone	0.000698	0.0011	CcSEcCtD
Ponatinib—Headache—Zoledronate—Paget's disease of bone	0.000694	0.00109	CcSEcCtD
Ponatinib—LCK—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.000689	0.00232	CbGpPWpGaD
Ponatinib—FGFR3—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000685	0.0023	CbGpPWpGaD
Ponatinib—Nausea—Zoledronate—Paget's disease of bone	0.000658	0.00104	CcSEcCtD
Ponatinib—FGFR4—Immune System—NUP205—Paget's disease of bone	0.000658	0.00221	CbGpPWpGaD
Ponatinib—LYN—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000643	0.00216	CbGpPWpGaD
Ponatinib—BCR—Disease—CALCA—Paget's disease of bone	0.00064	0.00215	CbGpPWpGaD
Ponatinib—LCK—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.000609	0.00205	CbGpPWpGaD
Ponatinib—FGFR4—Disease—NUP205—Paget's disease of bone	0.000608	0.00204	CbGpPWpGaD
Ponatinib—FGFR3—Disease—VCP—Paget's disease of bone	0.000588	0.00198	CbGpPWpGaD
Ponatinib—LCK—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000588	0.00198	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—PML—Paget's disease of bone	0.000582	0.00196	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—INPP5D—Paget's disease of bone	0.000561	0.00189	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—VCP—Paget's disease of bone	0.000557	0.00187	CbGpPWpGaD
Ponatinib—LCK—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000527	0.00177	CbGpPWpGaD
Ponatinib—LCK—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000518	0.00174	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—SQSTM1—Paget's disease of bone	0.000503	0.00169	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	0.000488	0.00164	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—NUP205—Paget's disease of bone	0.000487	0.00164	CbGpPWpGaD
Ponatinib—FGFR2—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000471	0.00158	CbGpPWpGaD
Ponatinib—KIT—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000462	0.00155	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000462	0.00155	CbGpPWpGaD
Ponatinib—SRC—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000459	0.00154	CbGpPWpGaD
Ponatinib—FGFR4—Disease—CALCA—Paget's disease of bone	0.000451	0.00152	CbGpPWpGaD
Ponatinib—FGFR3—Disease—NUP205—Paget's disease of bone	0.00045	0.00151	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—CALCA—Paget's disease of bone	0.000448	0.00151	CbGpPWpGaD
Ponatinib—LYN—Hemostasis—INPP5D—Paget's disease of bone	0.000447	0.0015	CbGpPWpGaD
Ponatinib—ABL1—Hemostasis—INPP5D—Paget's disease of bone	0.000445	0.00149	CbGpPWpGaD
Ponatinib—FGFR1—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000439	0.00147	CbGpPWpGaD
Ponatinib—PDGFRA—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000438	0.00147	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000433	0.00146	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—PML—Paget's disease of bone	0.00043	0.00145	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—INPP5D—Paget's disease of bone	0.000415	0.0014	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—VCP—Paget's disease of bone	0.000412	0.00138	CbGpPWpGaD
Ponatinib—FGFR2—Disease—VCP—Paget's disease of bone	0.000405	0.00136	CbGpPWpGaD
Ponatinib—KIT—Disease—VCP—Paget's disease of bone	0.000397	0.00134	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000386	0.0013	CbGpPWpGaD
Ponatinib—FGFR1—Disease—VCP—Paget's disease of bone	0.000377	0.00127	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—VCP—Paget's disease of bone	0.000376	0.00126	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—SQSTM1—Paget's disease of bone	0.000372	0.00125	CbGpPWpGaD
Ponatinib—LCK—Hemostasis—INPP5D—Paget's disease of bone	0.000366	0.00123	CbGpPWpGaD
Ponatinib—ABCG2—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.00036	0.00121	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—VCP—Paget's disease of bone	0.000359	0.00121	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—NUP205—Paget's disease of bone	0.000335	0.00113	CbGpPWpGaD
Ponatinib—FGFR3—Disease—CALCA—Paget's disease of bone	0.000334	0.00112	CbGpPWpGaD
Ponatinib—KIT—Immune System—NUP205—Paget's disease of bone	0.000329	0.00111	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000325	0.00109	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—INPP5D—Paget's disease of bone	0.000324	0.00109	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000316	0.00106	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—CALCA—Paget's disease of bone	0.000316	0.00106	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—NUP205—Paget's disease of bone	0.000312	0.00105	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—NUP205—Paget's disease of bone	0.000311	0.00105	CbGpPWpGaD
Ponatinib—FGFR2—Disease—NUP205—Paget's disease of bone	0.000309	0.00104	CbGpPWpGaD
Ponatinib—KIT—Disease—NUP205—Paget's disease of bone	0.000304	0.00102	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—PML—Paget's disease of bone	0.000296	0.000995	CbGpPWpGaD
Ponatinib—KIT—Immune System—PML—Paget's disease of bone	0.000291	0.000977	CbGpPWpGaD
Ponatinib—FGFR1—Disease—NUP205—Paget's disease of bone	0.000288	0.000969	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—NUP205—Paget's disease of bone	0.000287	0.000966	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—INPP5D—Paget's disease of bone	0.000286	0.00096	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—VCP—Paget's disease of bone	0.000283	0.000952	CbGpPWpGaD
Ponatinib—KIT—Immune System—INPP5D—Paget's disease of bone	0.00028	0.000943	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—INPP5D—Paget's disease of bone	0.00028	0.000942	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—VCP—Paget's disease of bone	0.000278	0.000935	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—PML—Paget's disease of bone	0.000276	0.000927	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—PML—Paget's disease of bone	0.000275	0.000925	CbGpPWpGaD
Ponatinib—LYN—Immune System—NUP205—Paget's disease of bone	0.000275	0.000923	CbGpPWpGaD
Ponatinib—ABL1—Immune System—NUP205—Paget's disease of bone	0.000273	0.000919	CbGpPWpGaD
Ponatinib—LCK—Disease—VCP—Paget's disease of bone	0.000272	0.000914	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—INPP5D—Paget's disease of bone	0.000266	0.000895	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—INPP5D—Paget's disease of bone	0.000265	0.000892	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—VCP—Paget's disease of bone	0.000264	0.000887	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—VCP—Paget's disease of bone	0.000263	0.000885	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—SQSTM1—Paget's disease of bone	0.000256	0.00086	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—NUP205—Paget's disease of bone	0.000255	0.000857	CbGpPWpGaD
Ponatinib—KIT—Immune System—SQSTM1—Paget's disease of bone	0.000251	0.000845	CbGpPWpGaD
Ponatinib—LYN—Immune System—PML—Paget's disease of bone	0.000243	0.000816	CbGpPWpGaD
Ponatinib—ABL1—Immune System—PML—Paget's disease of bone	0.000242	0.000812	CbGpPWpGaD
Ponatinib—SRC—Disease—VCP—Paget's disease of bone	0.000241	0.000809	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000241	0.000809	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—SQSTM1—Paget's disease of bone	0.000239	0.000802	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—SQSTM1—Paget's disease of bone	0.000238	0.0008	CbGpPWpGaD
Ponatinib—LYN—Immune System—INPP5D—Paget's disease of bone	0.000234	0.000787	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—CALCA—Paget's disease of bone	0.000234	0.000785	CbGpPWpGaD
Ponatinib—ABL1—Immune System—INPP5D—Paget's disease of bone	0.000233	0.000783	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—VCP—Paget's disease of bone	0.000232	0.000781	CbGpPWpGaD
Ponatinib—FGFR2—Disease—CALCA—Paget's disease of bone	0.00023	0.000771	CbGpPWpGaD
Ponatinib—KIT—Disease—CALCA—Paget's disease of bone	0.000225	0.000758	CbGpPWpGaD
Ponatinib—LCK—Immune System—NUP205—Paget's disease of bone	0.000225	0.000757	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—INPP5D—Paget's disease of bone	0.000218	0.000731	CbGpPWpGaD
Ponatinib—FGFR1—Disease—CALCA—Paget's disease of bone	0.000214	0.000719	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—CALCA—Paget's disease of bone	0.000213	0.000717	CbGpPWpGaD
Ponatinib—LYN—Immune System—SQSTM1—Paget's disease of bone	0.00021	0.000706	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—SQSTM1—Paget's disease of bone	0.00021	0.000705	CbGpPWpGaD
Ponatinib—ABL1—Immune System—SQSTM1—Paget's disease of bone	0.000209	0.000702	CbGpPWpGaD
Ponatinib—LCK—Disease—NUP205—Paget's disease of bone	0.000208	0.000698	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—CALCA—Paget's disease of bone	0.000204	0.000684	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	0.0002	0.000673	CbGpPWpGaD
Ponatinib—SRC—Immune System—NUP205—Paget's disease of bone	0.000199	0.00067	CbGpPWpGaD
Ponatinib—LCK—Immune System—PML—Paget's disease of bone	0.000199	0.000669	CbGpPWpGaD
Ponatinib—ABCB1—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000195	0.000654	CbGpPWpGaD
Ponatinib—LCK—Immune System—INPP5D—Paget's disease of bone	0.000192	0.000645	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—VCP—Paget's disease of bone	0.00019	0.00064	CbGpPWpGaD
Ponatinib—SRC—Disease—NUP205—Paget's disease of bone	0.000184	0.000618	CbGpPWpGaD
Ponatinib—SRC—Immune System—PML—Paget's disease of bone	0.000176	0.000592	CbGpPWpGaD
Ponatinib—LCK—Immune System—SQSTM1—Paget's disease of bone	0.000172	0.000578	CbGpPWpGaD
Ponatinib—SRC—Immune System—INPP5D—Paget's disease of bone	0.00017	0.000571	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—NUP205—Paget's disease of bone	0.000169	0.000567	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—VCP—Paget's disease of bone	0.000169	0.000567	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000166	0.000556	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000163	0.000546	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—CALCA—Paget's disease of bone	0.000161	0.00054	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—CALCA—Paget's disease of bone	0.000158	0.000531	CbGpPWpGaD
Ponatinib—LCK—Disease—CALCA—Paget's disease of bone	0.000154	0.000518	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000154	0.000518	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000154	0.000517	CbGpPWpGaD
Ponatinib—SRC—Immune System—SQSTM1—Paget's disease of bone	0.000152	0.000512	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—CALCA—Paget's disease of bone	0.00015	0.000503	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—CALCA—Paget's disease of bone	0.000149	0.000502	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—INPP5D—Paget's disease of bone	0.000144	0.000483	CbGpPWpGaD
Ponatinib—SRC—Disease—CALCA—Paget's disease of bone	0.000137	0.000459	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000136	0.000456	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CALCA—Paget's disease of bone	0.000132	0.000443	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—NUP205—Paget's disease of bone	0.000121	0.000406	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000111	0.000374	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CALCA—Paget's disease of bone	0.000108	0.000363	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—NUP205—Paget's disease of bone	0.000105	0.000352	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—INPP5D—Paget's disease of bone	0.000103	0.000346	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—SQSTM1—Paget's disease of bone	9.85e-05	0.000331	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CALCA—Paget's disease of bone	9.56e-05	0.000321	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—NUP205—Paget's disease of bone	9.12e-05	0.000306	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—INPP5D—Paget's disease of bone	8.92e-05	0.0003	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—NUP205—Paget's disease of bone	8.59e-05	0.000289	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—INPP5D—Paget's disease of bone	7.77e-05	0.000261	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—INPP5D—Paget's disease of bone	7.33e-05	0.000246	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—NUP205—Paget's disease of bone	5.62e-05	0.000189	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—INPP5D—Paget's disease of bone	4.79e-05	0.000161	CbGpPWpGaD
